|

The ROAD 2.0 to Sustainable Medication Use: Redispensing Unused Oral Anticancer Drugs

RECRUITINGN/ASponsored by Radboud University Medical Center
Actively Recruiting
PhaseN/A
SponsorRadboud University Medical Center
Started2024-01-10
Est. completion2024-12-31
Eligibility
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06566560

Summary

The goal of this prospective intervention study is to investigate the effectiveness of redispensing unused oral anticancer drugs. The main questions it aims to answer are: * What are the cost-savings of redispensing unused oral anticancer drugs? * What is the environmental impact of redispensing unused oral anticancer drugs? Researchers will compare redispensing unused oral anticancer drugs to the standard practice of disposal. Participants will receive their oral anticancer drugs in a sealed bag with a temperature indicator if needed. They will be asked to return any unused oral anticancer drugs to the pharmacy during their next visit to the hospital.

Eligibility

Healthy volunteers accepted
Inclusion Criteria:

* Patients of all ages
* A clinical diagnosis of cancer using an oral anticancer drug that requires storage at room temperature according to the Summary of Product Characteristics (SmPC).

Exclusion Criteria:

* Patients that do not understand the Dutch or English language, in written or spoken.
* Patients receiving prescriptions that contain an amount of tablets that deviates from the regular package size, resulting in the pharmacy dispensing an opened package

Conditions4

CancerDrug PrescriptionsOncologyPharmacy

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.